Nizatidine

Chemical formula: C₁₂H₂₁N₅O₂S₂  Molecular mass: 331.45 g/mol  PubChem compound: 3033637

Therapeutic indications

Nizatidine is indicated for:

Duodenal ulcer

Population group: only adults (18 years old or older)

Duodenal ulcer disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gastric ulcer

Population group: only adults (18 years old or older)

Gastric ulcer

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of duodenal ulcer recurrence

Population group: only adults (18 years old or older)

Preventive procedure and additionally Duodenal ulcer disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of gastric ulcer recurrence

Population group: only adults (18 years old or older)

Preventive procedure and additionally Gastric ulcer

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gastric oesophageal reflux disease

Population group: only adults (18 years old or older)

Gastroesophageal reflux disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2016: NIZATIDINE Capsule, hard
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈